Evaluation of Technological Innovation in Radiotherapy
Launched by CENTRE HOSPITALIER DE L'UNIVERSITÉ DE MONTRÉAL (CHUM) · Dec 14, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how we can better understand the effects of radiotherapy, a common treatment for cancer, and the side effects it may cause. The study aims to collect important information from patients who are receiving standard radiotherapy, including their experiences and any changes in their health over time. By gathering this data, researchers hope to improve the way we deliver radiotherapy and help future patients.
If you are between the ages of 65 and 74 and currently receiving radiotherapy or brachytherapy (a specific type of radiation treatment), you may be eligible to participate. As a participant, you would help researchers gather valuable information while receiving your regular treatment. The study is currently recruiting participants, so you could potentially contribute to important advancements in cancer care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ability to provide informed consent
- • Receiving radiotherapy or brachytherapy
- Exclusion Criteria:
- • -
About Centre Hospitalier De L'université De Montréal (Chum)
The Centre Hospitalier de l'Université de Montréal (CHUM) is a leading academic health institution in Canada, dedicated to advancing patient care through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHUM is committed to leveraging its multidisciplinary expertise and state-of-the-art facilities to facilitate groundbreaking studies that enhance medical knowledge and improve health outcomes. Collaborating with a network of healthcare professionals and researchers, CHUM fosters a rigorous research environment that prioritizes patient safety, ethical standards, and scientific integrity, positioning itself at the forefront of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Montréal, Quebec, Canada
London, Ontario, Canada
Laval, Quebec, Canada
Québec, Quebec, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials